-+ 0.00%
-+ 0.00%
-+ 0.00%

BioLineRx files initial beneficial ownership statement; CEO Philip A. Serlin reports 5.1 million ordinary shares owned directly

Reuters·03/27/2026 20:07:28

Please log in to view news